Cargando…
2900. High Rates of Experienced and Witnessed Opioid Overdose in PWID Receiving HCV Treatment: Data From the ANCHOR Study
BACKGROUND: People who inject drugs (PWID) have significant morbidity and mortality associated with hepatitis C (HCV); however, harms associated with ongoing injecting drug use (IDU)—such as opioid overdose—may pose a more imminent risk, and often are not addressed as part of HCV treatment. Naloxone...
Autores principales: | Rosenthal, Elana S, Nussdorf, Laura, D’Amore, Aaron, Brokus, Christopher, Silk, Rachel, Eyasu, Rahwa, Mathur, Poonam, Bijole, Phyllis, Jones, Miriam, Kier, Randy, Sternberg, David, Masur, Henry, Kottilil, Shyam, Kattakuzhy, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808729/ http://dx.doi.org/10.1093/ofid/ofz359.178 |
Ejemplares similares
-
2897. Collocated Buprenorphine Is Associated with Improved HCV Visit Adherence in People Who Inject Drugs (PWID): Data From the ANCHOR Study
por: Rosenthal, Elana S, et al.
Publicado: (2019) -
Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment
por: Brokus, Christopher, et al.
Publicado: (2021) -
859. Suboptimal Uptake, Retention, and Adherence of Daily Oral PrEP Among People with OUD Receiving HCV Treatment
por: Brokus, Christopher J, et al.
Publicado: (2021) -
PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV
por: Hill, Kristi C, et al.
Publicado: (2022) -
1297. Characteristics for PrEP Uptake, Retention, and Discontinuation: Data From the ANCHOR Study
por: Mathur, Poonam, et al.
Publicado: (2018)